Infections in solid-organ transplant recipients

American Journal of Infection Control

Volumn 25, Issue 5, 1997, Pages 409-417

  Singh, Nina ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; COTRIMOXAZOLE; GANCICLOVIR; HEPATITIS B SURFACE ANTIBODY; NYSTATIN; OKT 3;

ASPERGILLUS; CANDIDA; CRYPTOCOCCUS; CYTOMEGALOVIRUS; ENTEROCOCCUS FAECALIS; EPSTEIN BARR VIRUS; GRAM NEGATIVE INFECTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; INTRAVENOUS DRUG ADMINISTRATION; LEGIONELLA; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PNEUMOCYSTIS CARINII; POSTOPERATIVE INFECTION; PSEUDOMONAS AERUGINOSA; REVIEW; TOXOPLASMA GONDII; VARICELLA ZOSTER VIRUS;

EID: 0030753562     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(97)90089-4     Document Type: Article

References (43)

1. Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis 1996;22:537-49.
2. Wreghitt TG, Hakim M, Gray JS, Kucia S. Cytomegalovirus infections in heart and heart and lung transplant recipients. J Clin Pathol 1988;41:660-7.
3. The TH, van der Bij W, van der Berg AP, van der Giessen M, Weits J, Sprenger HG, et al. Cytomegalovirus antigenemia. Rev Infect Dis 1990;12(suppl):737-44.
4. Crumpacker CS. Ganciclovir. N Engl J Med 1996;335:721-9.
5. Sawyer M, Mayoral JL, Gillingham KJ, Kramer MA, Dunn DL. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg 1993;128:165-70.
6. Nalesnik M, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci 1994;4:61-79.
7. Kusne S, Schwartz M, Breinig MK, Dummer JS, Lee RE, Selby R, et al: Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis 1991;163:1001-7.
8. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124:1065-71.
9. Gane EJ, Portman BC, Naumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-20.
10. Singh N, Gayowski T, Wannstedt C, Marino R, Wagener MM. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy. 1996;10:348-51.
11. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994;20:773-9.
12. Gane EJ, Tibbs CJ, Ramage JK, Postmann BD, Williams R. Ribavirin therapy for hepatitis C infection following liver transplantation. Transplant Int 1995;8:61-4.
13. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 1993;329:1842-7.
14. Singh N, Gayowski T. Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995;59:1629-30.
15. Boker KHW, Ringe B, Druger M, Richlmayr R, Manns MP. Prostaglandin plus famciclovir: a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994;12:1706-8.
16. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH. Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis 1991;1:537-47.
17. Schwarz A, Offerman G, Keller F, Bennhold I, L'age-Stehr J, Krause PH, et al. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation: data on four cases and a review of the literature. Transplantation 1992;55:95-103.
18. Wagener MM, Yu VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992;20:239-47.
19. Lumbreras C, Fernandez I, Velosa J, Munn S, Sterioff S, Paya CV. Infectious complications following pancreatic transplantation: incidence, microbiological, clinical characteristics and outcome. Clin Infect Dis 1995;20:514-20.
20. Lynch JP, Martinez FJ. Pulmonary infections to watch for in transplant recipients. J Respir Dis 1993;14:528-50.
21. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation, an analysis of 101 consecutive cases. Medicine 1988;67:132-43.
22. Singh N, Muder RR, Yu VL. Legionella infection in liver transplant recipients: implications for management. Transplantation 1993;15:677-88.
23. Wade JJ, Rolando N, Hallar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995;21:1328-66.
24. Singh N, Gayowski T, Wagener M, Marino IR. Bloodstream infections in liver transplant recipients: changing patterns of microbial origin [abstract]. Presented at 36th Interscience Conference on Antimicrobial Agents and Chemotherapy 1996; New Orleans, La.
25. Linden PK, Pasculle AW, Manez R, Kramer DE, Fung JJ, Pinna AD, et al. Differences in outcome for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin susceptible E. faecium. Clin Infect Dis 1996;22:663-70.
26. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-88.
27. Torre-Cisnero J, Lopez OL, Kusne S, Martinez AJ, Starzl TE. CNS aspergillosis in organ transplantation: a clinicopathologic study. J Neurol Neurosurg Psychiatry 1993; 56:188-93.
28. Singh N, Rihs JD, Gayowski T, Yu VL. Cutaneous cryptococcosis mimicking bacterial cellulitis in a liver transplant recipient: case report and review in solid organ transplant recipients. J Clin Transplantation 1994;8:365-8.
29. Dummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir Infections 1990;5:50-7.
30. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. Primary and reactivated Toxoplasma infection in patients with cardiac transplants. Ann Intern Med 1983;99:27-31.
31. Petri WA. Infections in heart transplant recipients. Clin Infect Dis 1994;18:141-8.
32. Fishman JA, Rubin RH, Koziel MJ, Periera BJG. Hepatitis C virus and organ transplantation. Transplantation 1996;62:147-54.
33. Balfour HH, Chace BA, Stepleton JT, Simmons RR, Fryd DS. A randomized, placebo controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 1989;320:1381-7.
34. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1993;326:1182-6.
35. Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomized comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver transplant recipients. Lancet 1995;346:69-74.
36. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients, a randomized trial. Ann Intern Med 1994;120:375-81.
37. Samuel D, Bismuth H. Liver transplantation for hepatitis B. Gastroenterol Clin North Am 1993;22:271-83.
38. Arnow PM, Carandang GC, Zabner R, Irwin ME. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 1996;22:997-1003.
39. Allegheny County Health Department. Approaches to prevention and control of Legionella infection in Allegheny County health care facilities. Allegheny County Health Department 1993; April 1993.
40. Yu VL. Legionella pneumophila (Legionnaires' disease). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 2087-97.
41. Linden P, Pinna AD, Mazareiogos G, Furkuwa H, Kramer DJ, Kusne S. Outcome of liver transplantation in patients colonized with vancomycin-resistant E. faecium (VREF). Presented at 35th Interscience Conference on Antimicrobial Agents and Chemotherapy 1995; [Abstract J 72]; San Francisco, Calif.
42. Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. Transplantation 1995;59:45-50.
43. Singh N, Mieles L, Yu VL, Gayowski T. Invasive aspergillosis in liver transplant recipients: association with candidemia, consumption coagulopathy, and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis 1993;17:906-8.